Maintenance of blood pressure in normotensive dogs by endothelin

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 276, Issue 3 45-3, 1999, Pages

  Münter, Klaus ^a   Ehmke, Heimo ^b   Kirchengast, Michael ^a  

^a Preclinical Cardiology   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Angiotensin II receptor blockade; Angiotensin converting enzyme inhibition; Endothelin receptor blockade; Nitric oxide

Indexed keywords

ANGIOTENSIN RECEPTOR; DARUSENTAN; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIN; ENDOTHELIN A RECEPTOR; LOSARTAN; TRANDOLAPRIL;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE REGULATION; BLOOD VESSEL TONE; DOG; HORMONAL REGULATION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 0344334072     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1999.276.3.h1022     Document Type: Article

References (29)

1. Balakrishnan, S. M., H. D. Wang, V. Gopalakrishnan, T. W. Wilson, and R. J. McNeill. Effect of an endothelin antagonist on hemodynamic responses to angiotensin II. Hypertension 28: 806-809, 1996.
2. A receptors for endothelin regulation. Biochem. Biophys. Res. Commun. 238: 861-865, 1997.
3. A) receptor antagonist in conscious rats. J. Cardiovasc. Pharmacol. 20: 940-948, 1992.
4. Bird, E. J., S. D. Moreland, T. L. Waldron, and J. R. Powell. Antihypertensive effects of a novel endothelin-A receptor antagonist in rats. Hypertension 25: 1191-1195, 1995.
5. Christ, D. D., P. C. Wong, Y. N. Wong, S. D. Hart, C. Y. Quon, and G. N. Lam. The pharmacokinetics and pharmacodynamics of the angiotensin II receptor antagonist losartan potassium (DuP 753/MK 954) in the dog. J. Pharmacol. Exp. Ther. 268: 1199-1205, 1994.
6. Chua, B. H. L., C. C. Chua, C. A. Diglio, and B. B. Siu. Regulation of endothelin-1 mRNA by angiotensin II in rat heart endothelial cells. Biochim. Biophys. Acta 1178: 201-206, 1993.
7. Clavell, A. L., M. T. Mattingly, T. L. Stevens, A. Nir, S. Wright, L. L. Aarhus, D. M. Heublein, and J. C. Burnett. Angiotensin converting enzyme inhibition modulates endogenous endothelin in chronic canine thoracic inferior vena caval constriction. J. Clin. Invest. 97:1286-1292, 1996.
8. Clozel, M., V. Breu, G. A. Gray, B. Kalina, B.-M. Löffler, K. Burri, J.-M. Cassal, G. Hirth, M. Müller, and W. Neidhart. Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist. J. Pharmacol. Exp. Ther. 270: 228-235, 1994.
9. A-receptor blockade in angiotensin II-induced hypertension. Hypertension 29: 435-441, 1997.
10. Donckier, J. E., P.-E. Massart, D. Hodeige, H. van Mechelen, J.-P. Clozel, O. Laloux, J.-M. Ketelslegers, A. A. Charlier, and G. R. Heyndrickx. Additional hypotensive effect of endothelin-1 receptor antagonism in hypertensive dogs under angiotensin-converting enzyme inhibition. Circulation 96: 1250-1256, 1997.
11. Donckier, J. E., L. Stoleru, W. Hayashida, H. van Mechelen, P. Selvais, L. Galanti, J.-P. Clozel, J.-M. Ketelslegers, and H. Pouleur. Role of endogenous endothelin-1 in experimental renal hypertension in dogs. Circulation 92: 96-113, 1995.
12. Douglas, S. A., M. Gellai, M. Ezekiel, G. Z. Feuerstein, J. D. Elliott, and E. H. Ohlstein. Antihypertensive actions of the novel nonpeptide endothelin receptor antagonist SB 209670. Hypertension 25: 818-822, 1995.
13. B receptors. J. Appl. Physiol. 81: 1510-1515, 1996.
14. Hergenröder, S., K. Mun̈ter, A. Safer, and M. Kirchengast. Antihypertensive effect of a verapamil-trandolapril combination in hypertensive rats. Pharm. Pharmacol. Lett. 7: 33-36, 1997.
15. Karam, H., D. Heudes, P. Bruneval, M. F. Gonzales, B.-M. Löffler, M. Clozel, and J.-P. Clozel. Endothelin antagonism in end-organ damage of spontaneously hypertensive rats: comparison with angiotensin-converting enzyme inhibition and calcium antagonism. Hypertension 28: 379-385, 1996.
16. Lüscher, T. F., B. Seo, and F. R. Bühler. Potential role of endothelin in hypertension. Hypertension 21: 752-757, 1993.
17. Massart, P.-E., D. Hodeige, H. van Mechelen, A. A. Charlier, J.-M. Ketelslegers, G. R. Heyndrickx, and J. E. Donckier. Angiotensin II and endothelin-1 receptor antagonists have cumultative hypotensive effects in canine PAGE hypertension. J. Hypertens. 16: 835-841, 1998.
18. A-receptor antagonist. Circulation 96: 1593-1597, 1997.
19. Münter, K., and E. Hackenthal. The effects of endothelin on renovascular resistance and renin release. J. Hypertens. Suppl. 7: S276-S277, 1989.
20. A-receptor antagonist inhibits neointima formation induced by endothelial injury. Pharm. Pharmacol. Lett. 6: 90-92, 1996.
21. Richard, V., M, Hogie, M. Clozel, B.-M. Löffler, and C. Thuillez. In vivo evidence of an endothelin-induced vasopressor tone after inhibition of nitric oxide synthesis in rat. Circulation 91: 771-775, 1995.
22. Riechers, H., H.-P. Albrecht, W. Amberg, E. Baumann, H. Bernard, H.-J. Böhm, D. Klinge, A. Kling, S. Müller, M. Raschack, L. Unger, N. Walker, and W. Wernet. Discovery and optimization of a novel class of orally active nonpeptidic endothelin-A receptor antagonists. J. Med. Chem. 39: 2123-2128, 1996.
23. Sakurai, T., M. Yanagisawa, and T. Masaki. Molecular characterization of endothelin receptors. Trends Pharmacol. Sci. 13: 103-108, 1992.
24. Schiffrin, E. L. Endothelin: potential role in hypertension and vascular hypertrophy. Hypertension 25: 1135-1143, 1995.
25. A-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats. Br. J. Pharmacol. 121: 935-940, 1997.
26. Teerlink, J. R., J. P. Carteaux, U. Sprecher, B.-M. Löffler, M. Clozel, and J.-P. Clozel. Role of endogenous endothelin in normal hemodynamic status of anesthetized dogs. Am. J. Physiol. 268 (Heart Circ. Physiol. 37): H432-H440, 1995.
27. Vanhoutte, P. M. Is endothelin involved in the pathogenesis of hypertension? Hypertension 21: 747-751, 1993.
28. Veniant, M., J.-P. Clozel, P. Hess, and M. Clozel. Endothelin plays a role in the maintenance of blood pressure in normotensive guinea pigs. Life Sci. 55: 445-454, 1994.
29. Yanagisawa, M., H. Kurihara, S. Kimura, Y. Tomobe, M. Kobayashi, Y. Mitsui, Y. Yazaki, K. Goto, and T. Masaki. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415, 1988.